about
The life and death of oligodendrocytes in vanishing white matter diseaseAcute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome.Magnetic resonance imaging spectrum of succinate dehydrogenase-related infantile leukoencephalopathy.Identification of naturally occurring fatty acids of the myelin sheath that resolve neuroinflammation.Disease specific therapies in leukodystrophies and leukoencephalopathies.Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.National variation in costs and mortality for leukodystrophy patients in US children's hospitalsAcute flaccid myelitis: A clinical review of US cases 2012-2015.Consensus statement on preventive and symptomatic care of leukodystrophy patients.Emerging treatments for pediatric leukodystrophies.Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies.A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012-14): a retrospective cohort study.Acute flaccid paralysis with anterior myelitis - California, June 2012-June 2014.Decision Making in Adrenoleukodystrophy: When Is a Good Outcome Really a Good Outcome?Pediatric Bickerstaff brainstem encephalitis: a systematic review of literature and case series.The unfolded protein response in vanishing white matter disease.Postmortem Whole Exome Sequencing Identifies Novel EIF2B3 Mutation With Prenatal Phenotype in 2 Siblings.Neonatal detection of Aicardi Goutières Syndrome by increased C26:0 lysophosphatidylcholine and interferon signature on newborn screening blood spots.Safety, tolerability, and efficacy of fluoxetine as an antiviral for acute flaccid myelitisDe Novo Mutations in the Motor Domain of KIF1A Cause Cognitive Impairment, Spastic Paraparesis, Axonal Neuropathy, and Cerebellar AtrophyClinical Subpopulations in a Sample of North American Children Diagnosed With Acute Flaccid Myelitis, 2012-2016Pneumonia Prevention Strategies for Children With Neurologic ImpairmentAllogeneic HSCT for adult-onset leukoencephalopathy with spheroids and pigmented gliaGenetic and phenotypic spectrum associated with IFIH1 gain-of-functionMeasuring early lesion growth in boys with cerebral demyelinating adrenoleukodystrophyClinical approach to the diagnosis of autoimmune encephalitis in the pediatric patientIncidence, Risk Factors and Outcomes Among Children With Acute Flaccid Myelitis: A Population-based Cohort Study in a California Health Network Between 2011 and 2016
P50
Q24297799-CA30B2A1-DAC8-42C8-AE33-B08CD57FAD15Q30248248-905D3723-6E09-43FB-9EF4-E3EDAB55D090Q31030671-446B68B4-6DED-49D0-B7F1-B88D355763B4Q34279465-3C51B65F-7300-4008-8322-2AC51385A2ACQ35328494-1618A02D-CA1A-4D85-85BF-5EBB58F9D321Q36645164-C79EEFE4-21DE-4E5F-9710-761119982E62Q37108450-EBD55875-9AB5-4AE4-A4E0-D047638629FFQ37397515-4C7BBB59-245F-4FC2-B90F-AAD870F1E0EEQ38313759-F39CF8D1-A46C-4AF2-A409-C3044EE9B924Q38506539-EE88925B-2E0F-416B-B48A-79605FBD78A8Q38634230-AF4643E6-B8EF-4457-B3F7-F99E05CC11E7Q41359548-6161B5A0-1386-4554-899E-77FB00E611C9Q41708945-396BAB8B-0354-4152-BCCF-157C50636975Q43966963-1FB4C586-61ED-40D3-8FD8-8102B6ACF1ADQ47570453-E7EBC19E-1C47-44FE-AEA3-B8DC453807BEQ48788070-B3817519-A66E-42A8-90B1-B1AFD6D39933Q52091965-32443B55-257C-4C36-BE90-EC08CF5B50F7Q53145595-82110315-F3B9-4C46-A8B2-51DC265CB111Q58568748-A9E0D2EA-B1F7-488F-88BD-A816300807FBQ59545957-0EEEC1D5-0186-4D74-AE9B-A31AB419B327Q89992627-D6DA4033-6082-4C9F-BF99-E2D8BCAD6D20Q90182308-FBA48091-3F4A-45B6-A0A6-16047D084AEDQ92000813-01A70D3E-927B-459C-A639-896BE8D65D59Q92395117-68AE6186-0E5E-489D-9457-3F5AE61E8A05Q92564099-B163F35E-6B9A-4B3D-9598-33FB10AA4BEEQ92739172-7F40E8B7-213A-46CE-8D6B-D3872EEEE966Q93094777-6E5DF5FE-82C6-4846-BBB3-6104D4B62963
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Keith van Haren
@ast
Keith van Haren
@en
Keith van Haren
@es
Keith van Haren
@nl
type
label
Keith van Haren
@ast
Keith van Haren
@en
Keith van Haren
@es
Keith van Haren
@nl
prefLabel
Keith van Haren
@ast
Keith van Haren
@en
Keith van Haren
@es
Keith van Haren
@nl
P106
P31
P496
0000-0002-0233-9361